Agile and results-driven Insights and Strategy professional with broad Healthcare experience from blue-chip companies (P&G, Teva, and RB Health).

I lead an outstanding team of consultants, experts and strategists in market research, competitive intelligence and market access at Lifescience Dynamics. Our team is comprised of passionate scientists who help humanity by aiding the development of medicines to defeat diseases.

We work alongside visionary leaders and their teams, providing them with the advice, tools, and support to bring amazing therapeutics, prophylaxis, diagnostics and medical devices to market, through HCPs, competitors, payers, policy makers and stakeholder engagements.

This is an exciting time at Lifescience Dynamics. We are at an inflection point in our growth trajectory. My goal as leader of Lifescience Dynamics is to have a company full of smart, passionate people who come to work every day asking, “So what?” “What now?” “What next?” and “Why not?”. We are united by a shared higher purpose, and our community of curious, innovative and dedicated people carry this integrity and humanism with them throughout their lives.

Managing the Group Competitive Intelligence across segments, fostering a secured, reliable, and efficient handling of external sources and BI platforms.

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients.

Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company with a more than 70-year heritage, the company applies cutting-edge science including an expertise in antibody research and engineering, to address the needs of patients and society across multiple therapeutic areas including Nephrology, Oncology, Immunology/Allergy and Neurology. Across its four regions – Japan, Asia Pacific, North America and EMEA/International – we focus on its purpose, to make people smile, and are united by our shared values of commitment to life, teamwork/Wa, innovation, and integrity.

Lifescience Dynamics works across five practice areas: Market Research, Competitive Intelligence, and Market Access, Strategic Advisory and Real-World Evidence. The company’s success is attributed to its multinational team who work in a collaborative and nurturing environment, where they can develop their skills and advance their careers. Founded in 2004, Lifescience Dynamics has its headquarters in London and an office in Toronto, as well as virtual offices in Boston, New York, San Francisco and Vancouver.

Founded to serve health, Servier is a global group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. The 21,400 employees of the Group are committed to this shared vocation, source of inspiration every day. As a world leader in cardiology, Servier's ambition is to become a focused and innovative player in oncology by targeting hard-to-treat cancers. That is why the Group allocates over 50% of its R&D budget to developing targeted and innovative therapies in oncology. Neuroscience and immuno-inflammatory diseases are the future growth drivers. In these areas, Servier is focused on a limited number of diseases in which accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote access to quality care for all at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, relying on strong brands in France, Eastern Europe, Brazil and Nigeria. In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine. Headquartered in France, Servier relies on a strong geographical footprint in over 150 countries and achieved a revenue of €4.9 billion in 2022.